Validity, reliability, and responsiveness of the EQ‐5D in inflammatory bowel disease in Germany

Background: The EuroQol (EQ)‐5D questionnaire is a generic instrument measuring health‐related quality of life. Its validity, reliability, and responsiveness were assessed in a large sample of Crohn's disease (CD) and ulcerative colitis (UC) patients. Methods: The EQ‐5D was completed initially...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Inflammatory bowel diseases 2010-01, Vol.16 (1), p.42-51
Hauptverfasser: Stark, Renee G., Reitmeir, Peter, Leidl, Reiner, König, Hans‐Helmut
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: The EuroQol (EQ)‐5D questionnaire is a generic instrument measuring health‐related quality of life. Its validity, reliability, and responsiveness were assessed in a large sample of Crohn's disease (CD) and ulcerative colitis (UC) patients. Methods: The EQ‐5D was completed initially (270 CD and 232 UC subjects) and after 4 weeks (447 subjects) with a transition question rating health change. Responsiveness of EQ visual analog scale (EQ‐VAS) and the United Kingdom (UK‐index) and German EQ‐5D index (EQ‐index) scores to reported changes in health was evaluated by standardized response means (SRM) and meaningful differences (MDs). Results: EQ‐VAS and EQ‐index scores correlated well with disease activity indices and differed significantly between active disease and remission groups. All scores were reliable in test–retest (ICC: EQ‐VAS: 0.89; UK‐index: 0.76; German EQ‐index: 0.72). According to SRM, EQ‐VAS was more responsive for deterioration in health than for improvement in health and was more responsive than index scores. Index scores were most responsive for deterioration in health in subjects in remission and for improved health in subjects with active disease. MDs for improved health (EQ‐VAS: 10.9; UK EQ‐index: 0.076; German EQ‐index: 0.050) and deteriorated health (EQ‐VAS: −14.4; UK EQ‐index: −0.109; German EQ‐index: −0.067) were significant, but MD of EQ‐VAS also differed significantly according to disease activity. Conclusions: The EQ‐5D generates valid, reliable, and responsive preference‐based valuations of health in CD and UC. EQ‐VAS scores were more responsive than EQ‐5D index scores. Thus, small health differences that are important from the patient's perspective may not be reflected in the EQ‐index. Inflamm Bowel Dis 2010
ISSN:1078-0998
1536-4844
DOI:10.1002/ibd.20989